MFDS
- Marketing authorisation holder: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- Status: likely_approved
🇰🇷 Anktiva in South Korea
Anktiva (INBAKICEPT) regulatory status in South Korea.
Marketing authorisation
Anktiva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Anktiva approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Anktiva in South Korea?
ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU holds the South Korean marketing authorisation.